Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


July 02, 2015 1:32 AM ET

Pharmaceuticals

Company Overview of Quark Pharmaceuticals, Inc.

Key Executives for Quark Pharmaceuticals, Inc.

NameBoard RelationshipsTitleAge
Daniel Zurr Ph.D.20 RelationshipsFounder, Chief Executive Officer, President, Director and Member of Compensation Committee69
Tomer Natan LLM, BB, CPANo RelationshipsChief Financial Officer--
Rami Skaliter Ph.D.No RelationshipsChief Operating Officer57
Shai S. Erlich Ph.D.No RelationshipsChief Medical Officer49
Juliana Friedmann M.Sc.No RelationshipsSenior Vice President of Strategy & Planning63

Quark Pharmaceuticals, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Philip B. Simon J.D., CPA 27 RelationshipsLawrence Investments, LLC62
Daniel Zurr Ph.D. 20 RelationshipsQuark Pharmaceuticals, Inc.69
Philip M. Hahn 20 RelationshipsBrown University73
André G. Pernet Ph.D., M.B.A 44 RelationshipsGenset Corporation70
Dov Weinberger M.D. 20 RelationshipsQuark Pharmaceuticals, Inc.--
View All Board Members

Quark Pharmaceuticals, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Audit Committee J.D., CPAPhilip B. Simon27 Relationships2 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary$322.3K
322.3K
469.3K
Bonus$135.0K
135.0K
542.8K
Total Short Term Compensation
Not meaningful
Total Value of Options$457.3K
457.3K
23.0M
Compensation as of Fiscal Year 2010
Quark Pharmaceuticals, Inc. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

Vinda International Holdings Limited Announces Board Changes
June 30, 2015 8:30 AM ET
Pee Cee Cosma Sope Ltd Announces Executive Changes
June 23, 2015 9:49 AM ET
Kimberly-Clark Elects Michael D. White to its Board of Directors
June 22, 2015 1:00 PM ET
Hipolin Announces Resignation of Nilesh Rajnikant Desai as Independent Director
June 10, 2015 10:30 AM ET
Frank A. Tataseo, Executive Vice President - New Business Development to Retire from the Clorox Company, Effective October 1, 2015
June 03, 2015 9:00 PM ET

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Quark Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.